SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Population-Wide Screening for Chronic Kidney Disease
10 references·0 citing·45 second hop
Population-Wide Screening for Chronic Kidney Disease (2023)Population-Wide Screening for Chronic Kid…A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)A Health Opportunity Cost Thr…Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Recommendations for Conduct, …Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States (2016)Adjusting Health Expenditures…Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Updating Cost-Effectiveness —…Model Parameter Estimation and Uncertainty Analysis (2012)Model Parameter Estimation an…United States Life Tables, 2021. (2010)United States Life Tables, 20…A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening (2010)A Health Policy Model of CKD:…Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores (2006)Report of Nationally Represen…Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Representing uncertainty: the…Estimating CE Ratios under Second-order Uncertainty (1997)Estimating CE Ratios under Se…A 12-Item Short-Form Health Survey (1996)Cost-Effectiveness in Health and Medicine (1996)EQ-SD: a measure of health status from the EuroQol Group (2001)Danish EQ-5D population norms (2009)Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets (2010)Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQ O L) (2011)Network meta‐analysis for indirect treatment comparisons (2002)Decision Modelling For Health Economic Evaluation (2006)Uncertain Judgements: Eliciting Experts' Probabilities (2006)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study (2012)Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review (2023)Net Health Benefits (1998)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility (2004)Critical ratios and efficient allocation (1973)Accounting for future costs in medical cost-effectiveness analysis (1997)Economic foundations of cost-effectiveness analysis (1997)Uncertainty in Decision Models Analyzing Cost-Effectiveness (1998)Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses (2001)Uncertainty and Patient Heterogeneity in Medical Decision Models (2010)Methods for the Economic Evaluation of Health Care Programmes (2005)Understanding Costs of Care in the Operating Room (2018)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Is Technological Change In Medicine Worth It? (2001)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries (2017)Trends in Treatment and Spending for Patients Receiving Outpatient Treatment of Depression in the United States, 1998-2015 (2019)Trends in Health Care Use Among Black and White Persons in the US, 1963-2019 (2022)Medical Care Costs: How Much Welfare Loss? (1992)The Oregon Health Insurance Experiment: Evidence from the First Year* (2012)Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life (2021)Cost-effectiveness Thresholds Used by Study Authors, 1990-2021 (2023)Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis (2024)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)Economics and mental health: the current scenario (2020)Trends in the Educational Gradient of U.S. Adult Mortality From 1986 Through 2006 by Race, Gender, and Age Group (2011)A Life Course Perspective on How Racism May Be Related to Health Inequities (2012)Mortality and Access to Care among Adults after State Medicaid Expansions (2012)
this work references cited by second hop

References

  • 2016Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses3,063 cited
  • 2014Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2,247 cited
  • 2001Representing uncertainty: the role of cost‐effectiveness acceptability curves1,111 cited
  • 2012Model Parameter Estimation and Uncertainty Analysis886 cited
  • 2016Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States494 cited
  • 2006Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for 7 Health-Related Quality-of-Life Scores395 cited
  • 2020A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States242 cited
  • 2010United States Life Tables, 2021.224 cited
  • 2010A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening135 cited
  • 1997Estimating CE Ratios under Second-order Uncertainty124 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work